Jayme de la té y sagáu

pp. 141-183

Por una (hiper)pedagogía crítica, intercultural y multisensorial en el aprendizaje de Español como Lengua Extranjera (ELE)

Teniendo en cuenta una pedagogía crítica emancipadora (Jiménez Raya, Lamb & Vieira, 2007) enriquecida por enfoques multisensoriales (Arslan, 2009), se pretende en este artículo dar cuenta de prácticas verdaderamente interdisciplinarias y basadas en una filosofía de proyecto en el que alumnos de ELE en la Educación Básica (primer y tercer ciclos) llevan a cabo tareas de naturaleza plurilingüe y multicultural.En este estudio, hemos tratado de destacar las prácticas y estrategias emancipatorias que traducen aprendizajes que resultan significativos en un nivel multicultural y plurilingüe para los alumnos (Andrade & Araújo e Sá, 2003), contribuyendo al desarrollo de su conciencia crítica cultural (Byram et al, 2002). Buscando evidenciar una muestra de prácticas interdisciplinarias y multisensoriales (Arslan, 2009), relacionadas con el proyecto Pluri+Red y basadas en el uso de estrategias y materiales físicos o digitales (juegos didácticos, WebQuests, cuentos interactivos, etc.) que plantean retos a los estudiantes con el fin de provocar asombro y extrañeza, pero también cuestionamiento (Jiménez Raya, Lamb & Vieira, 2007), pretendemos que este estudio exploratorio demuestre las opciones y rutas tomadas hacia un único objetivo: formar a los futuros ciudadanos conscientes del mundo, capaces de intervenir y de formarse a lo largo de su vida.

Treatment of chronic hepatitis C in non-responsive patients with pegylated interferon associated with ribavirin and thalidomide: report of six cases of total remission

Hepatitis C virus (HCV) infection is an important public health issue worldwide. It is estimated that over 170 million people are infected with the virus. The present study reports six cases in which patients did not respond to combination therapy with pegylated interferon and ribavirin. However, after the addition of thalidomide to the therapy, the patients presented negative RNA PCR. The use of thalidomide combined with pegylated interferon and ribavirin for the treatment of hepatitis C is described here for the first time in the related literature.

Cryoglobulinemia in chronic hepatitis C: clinical aspects and response to treatment with interferon alpha and ribavirin

INTRODUCTION: The main extra-hepatic manifestation of hepatitis C is mixed cryoglobulinemia (MC). The aim of this study was to evaluate its prevalence among patients with chronic hepatitis C (CHC), to correlate its presence to host and virological variables and to the response to combined therapy with interferon-alpha and ribavirin. CASUISTIC AND METHODS: 202 CHC naive patients (136 with chronic hepatitis and 66 with cirrhosis) were consecutively evaluated for the presence of cryoglobulins. Cryoprecipitates were characterized by immunoelectrophoresis and classified according to the Brouet's criteria. RESULTS: The prevalence of MC was 27% (54/202), and 24% of them (13/54) showed major clinical manifestation of the disease. Even though type III MC was more frequent (78%), symptomatic MC was more common in type II MC. The presence of cirrhosis (RR = 2.073; IC95% = 1.029 - 4.179; p = 0.041), and age of the patients (RR = 1.035; IC95% = 1.008 - 1.062; p = 0.01) were independently associated with the presence of cryoglobulins. No relationship was found with viral load and genotype. 102 patients were treated with interferon alpha and ribavirin. Among these, 31 had MC. Sustained virological response (around 30%) was similar in patients with and without MC (p = 0.971). CONCLUSION: MC represents a prevalent complication in patients with CHC, specially older and cirrhotic patients. Only 24% of these patients show clinical manifestation of the disease, specially those with type II MC. The presence of MC did not affect the response to therapy.

Upper Eyelid Reconstruction With a Horizontal V-Y Myotarsocutaneous Advancement Flap

Upper eyelid tumours, particularly basal cell carcinomas, are relatively frequent. Surgical ablation of these lesions creates defects of variable complexity. Although several options are available for lower eyelid reconstruction, fewer surgical alternatives exist for upper eyelid reconstruction. Large defects of this region are usually reconstructed with two-step procedures. In 1997, Okada et al. described a horizontal V-Y myotarsocutaneous advancement flap for reconstruction of a large upper eyelid defect in a single operative time. However, no further studies were published regarding the use of this particular flap in upper eyelid reconstruction. In addition, this flap is not described in most plastic surgery textbooks. The authors report here their experience of 16 cases of horizontal V-Y myotarsocutaneous advancement flaps used to reconstruct full-thickness defects of the upper eyelid after tumour excision. The tumour histological types were as follows: 12 basal cell carcinomas, 2 cases of squamous cell carcinomas, 1 case of sebaceous cell carcinoma and 1 of malignant melanoma. This technique allowed closure of defects of up to 60% of the eyelid width. None of the flaps suffered necrosis. The mean operative time was 30 min. No additional procedures were necessary as good functional and cosmetic results were achieved in all cases. No recurrences were noted. In this series, the horizontal V-Y myotarsocutaneous advancement flap proved to be a technically simple, reliable and expeditious option for reconstruction of full-thickness upper eyelid defects (as wide as 60% of the eyelid width) in a single operative procedure. In the future this technique may become the preferential option for such defects.